These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 16223890

  • 1. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
    Maeno Y, Inaba M, Okuno S, Yamakawa T, Ishimura E, Nishizawa Y.
    Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y.
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
    Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimura E, Nishizawa Y.
    Calcif Tissue Int; 2008 Apr; 82(4):278-87. PubMed ID: 18421493
    [Abstract] [Full Text] [Related]

  • 4. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
    Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Miki T, Kim M, Nishizawa Y.
    Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I.
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
    Amama EA, Taga M, Minaguchi H.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):333-8. PubMed ID: 9467536
    [Abstract] [Full Text] [Related]

  • 13. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
    Takahara K, Kamimura M, Hashidate H, Uchiyama S, Nakagawa H.
    J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
    [Abstract] [Full Text] [Related]

  • 14. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
    Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, Ward L.
    J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
    [Abstract] [Full Text] [Related]

  • 15. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Sugimoto K, Ikeya K, Iida T, Kawasaki S, Arai O, Umehara K, Watanabe F, Tani S, Oishi S, Osawa S, Yamamoto T, Hanai H.
    Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
    [Abstract] [Full Text] [Related]

  • 16. Chronic idiopathic neutropenia of adults is associated with decreased bone mineral density and alterations in bone turnover biochemical markers.
    Papadaki HA, Margioris AN, Miliaki M, Steriopoulos C, Valatas W, Eliopoulos GD.
    Eur J Haematol; 1999 May; 62(5):311-6. PubMed ID: 10359059
    [Abstract] [Full Text] [Related]

  • 17. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.
    Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S.
    Calcif Tissue Int; 1998 Aug; 63(2):102-6. PubMed ID: 9685512
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.